Does OCRELIZUMAB Cause Muscular weakness? 1,519 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,519 reports of Muscular weakness have been filed in association with OCRELIZUMAB (OCREVUS). This represents 2.7% of all adverse event reports for OCRELIZUMAB.
1,519
Reports of Muscular weakness with OCRELIZUMAB
2.7%
of all OCRELIZUMAB reports
7
Deaths
537
Hospitalizations
How Dangerous Is Muscular weakness From OCRELIZUMAB?
Of the 1,519 reports, 7 (0.5%) resulted in death, 537 (35.4%) required hospitalization, and 5 (0.3%) were considered life-threatening.
Is Muscular weakness Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OCRELIZUMAB. However, 1,519 reports have been filed with the FAERS database.
What Other Side Effects Does OCRELIZUMAB Cause?
Covid-19 (11,454)
Fatigue (5,704)
Urinary tract infection (3,618)
Headache (3,036)
Multiple sclerosis (2,609)
Asthenia (2,509)
Nasopharyngitis (2,479)
Gait disturbance (2,384)
Pneumonia (2,333)
Pain (2,327)
What Other Drugs Cause Muscular weakness?
ADALIMUMAB (3,605)
METHOTREXATE (2,813)
RITUXIMAB (2,621)
ATORVASTATIN (2,494)
PREDNISONE (2,236)
ETANERCEPT (2,207)
DALFAMPRIDINE (1,916)
TOCILIZUMAB (1,790)
FINGOLIMOD (1,769)
SECUKINUMAB (1,747)
Which OCRELIZUMAB Alternatives Have Lower Muscular weakness Risk?
OCRELIZUMAB vs OCRIPLASMIN
OCRELIZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OCRELIZUMAB vs OCTINOXATE\OCTOCRYLENE
OCRELIZUMAB vs OCTREOTIDE
OCRELIZUMAB vs OCTREOTIDE\OCTREOTIDE